Episode 719
TWiV 719: COVID-19 clinical update #49 with Dr. Daniel Griffin
February 13, 202127m 41s
Audio is streamed directly from the publisher (traffic.libsyn.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
In COVID-19 clinical update #49, Daniel Griffin discusses CDC guidelines on mask use, drop in test frequency in the US, resurgence of COVID-19 in Brazil, possible impact of Pfizer vaccine on viral load, EUA for bamlanivimab and etesevimab administered together, and preliminary results of Tocilizumab in hospitalized patients.
Hosts: Daniel Griffin and Vincent Racaniello
Subscribe (free): iTunes, Google Podcasts, RSS, email
Become a patron of TWiV!
Links for this episode- Resurgence of COVID-19 in Brazil (Lancet)
- Pfizer vaccine reduces viral load (medRxiv)
- EUA for bamlanivimab plus etesevimab (pdf)
- Tocilizumab in hospitalized patients (medRxiv)
- Bacterial superinfections in COVID-19 (Open For Inf Dis)
- Letters read on TWiV 719
- Timestamps by Jolene. Thanks!
Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to [email protected]